Results 241 to 250 of about 54,905 (262)
Rewriting the MASLD‐associated hepatocellular carcinoma script: Targeting epigenetics and metabolism
International Journal of Cancer, Volume 157, Issue 10, Page 1991-2003, 15 November 2025.Abstract Abnormal epigenetic patterns are crucial for the progression of metabolic‐associated steatotic liver disease (MASLD) and hepatocellular carcinoma (HCC) development. Recent research focused on the interplay between epigenetics and altered metabolic pathways in HCC from MASLD, suggesting that the reversibility of epigenetic changes offers ...
Chiara Aiello +7 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Interventional gastroenterology in oncology
Ca-A Cancer Journal for Clinicians, 2023Vaibhav Wadhwa
exaly
Global epidemiology of cirrhosis — aetiology, trends and predictions
Nature Reviews Gastroenterology and Hepatology, 2023Daniel Q Huang +2 more
exaly
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Nature Reviews Gastroenterology and Hepatology, 2022Daniel Q Huang, Rohit Loomba
exaly
Cirrhosis-associated immune dysfunction
Nature Reviews Gastroenterology and Hepatology, 2021Agustín Albillos +2 more
exaly
HER2-targeted therapies — a role beyond breast cancer
Nature Reviews Clinical Oncology, 2019Yung-Jue Bang
exaly
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
Nature Reviews Gastroenterology and Hepatology, 2020Jonel Trebicka +2 more
exaly